Measures for the primary<unk>  of Budd-Chiari<unk>  include effective management of predisposing conditions, chronic anticoagulation in patients with underlying hypercoagulable disorder, treat patients with an underlying myeloproliferative disorder with aspirin and hydroxyurea rather than anticoagulants such as warfarin.
Budd-Chiari syndrome primary prevention
Budd-Chiari syndrome secondary prevention
Gastrointestinal varices primary prevention
Gastrointestinal varices secondary prevention
Hepatic encephalopathy primary prevention
Ascites primary prevention
Upper gastrointestinal bleeding primary prevention
Cholangiocarcinoma primary prevention